Skip to main content

Controversies in Neonatal Sepsis: Immunomodulation in the Treatment and Prevention of Neonatal Sepsis

  • Conference paper
Hot Topics in Infection and Immunity in Children III

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 582))

  • 1340 Accesses

6. Conclusion

Whilst the concept of replacing the neonatal immunological deficit to prevent or treat systemic sepsis is theoretically attractive, the results from clinical trials performed to date are perhaps less dramatic than expected. The reasons for this are likely to be multifactorial, but include the recruitment of low risk infants who are not septic or neutropenic, and use of inappropriate immunoglobulin preparations that contains little or no antibody effective against pathogens causing neonatal sepsis. There may well be cheaper, more effective, but less glamorous, methods of preventing infection in the preterm infant. There is accumulating evidence regarding the role of prophylactic broad spectrum antibiotics on neonatal gut flora and the influence of early enteral feeding with a correct milk formula can have on encouraging “friendly” gut bacteria. The role of growth factors and immunoglobulin preparations in the treatment and prophylaxis of neonatal sepsis has not yet been established and these products should only be used in the context of large randomised controlled clinical trials until there is clear evidence of benefit (or absence of benefit) in their use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahmad, A., Laborada, G., Bussel, J., and Nesin, M. (2002). Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants. Pediatr Infect Dis J. 21:1061–1065.

    Article  PubMed  Google Scholar 

  • Baley, J.E., Stork, E.K., Warkentin, P.I., and Shurin, S.B. (1987). Buffy coat transfusions in neutropenic neonates with presumed sepsis: a prospective, randomized trial. Pediatrics. 80:712–720.

    PubMed  CAS  Google Scholar 

  • Bedford Russell, A.R., Emmerson, A.J., Wilkinson, N., Chant, T., Sweet, D.G., Halliday, H.L., Holland, B., and Davies, E.G. (2001). A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed. 84:F172–F176.

    Article  PubMed  CAS  Google Scholar 

  • Bernstein, H.M., Pollock, B.H., Calhoun, D.A., and Christensen, R.D. (2001). Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: A meta-analysis. J Pediatr. 138:917–920.

    Article  PubMed  CAS  Google Scholar 

  • Bilgin, K., Yaramis, A., Haspolat, K., Tas, M.A., Gunbey, S., and Derman, O. (2001). A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics. 107:36–41.

    Article  PubMed  CAS  Google Scholar 

  • Cairo, M.S., Worcester, C.C., Rucker, R.W., Hanten, S., Amlie, R.N., Sender, L., and Hicks, D.A. (1992). Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr. 120:281–285.

    Article  PubMed  CAS  Google Scholar 

  • Cairo, M.S., Christensen, R., Sender, L.S., Ellis, R., Rosenthal, J., van de Ven, C., Worcester, C., and Agosti, J.M. (1995). Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood. 86:2509–2515.

    PubMed  CAS  Google Scholar 

  • Cairo, M.S., Agosti, J., Ellis, R., Laver, J.J., Puppala, B., deLemos, R., Givner, L., Nesin, M., Wheeler, J.G., Seth, T., van de Ven, C., and Fanaroff, A. (1999). A randomized, double-blind, placebocontrolled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr. 134:64–70.

    Article  PubMed  CAS  Google Scholar 

  • Carr, R., and Davies, J.M. (1990). Abnormal FcRIII expression by neutrophils from very preterm neonates. Blood. 76:607–611.

    PubMed  CAS  Google Scholar 

  • Carr, R., Modi, N., Dore, C.J., El-Rifai, R., and Lindo, D. (1999). A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation. Pediatrics. 103:796–802.

    Article  PubMed  CAS  Google Scholar 

  • Carr, R., Modi, N., and Dore, C. (2003). G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev. 3:CD003066.

    Google Scholar 

  • Chen, J.Y. (1996). Intravenous immunoglobulin in the treatment of full-term and premature newborns with sepsis. J Formos Med Assoc. 95:839–844.

    PubMed  CAS  Google Scholar 

  • Christensen, R.D., and Rothstein, G. (1980). Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr. 96:316–318.

    Article  PubMed  CAS  Google Scholar 

  • Christensen, R.D., Anstall, H., and Rothstein, G. (1982a). Neutrophil transfusion on septic neutropenic neonates. Transfusion. 22:151–153.

    Article  PubMed  CAS  Google Scholar 

  • Christensen, R.D., Rothstein, G., Anstall, H.B., and Bybee, B. (1982b). Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils. Pediatrics. 70:1–6.

    PubMed  CAS  Google Scholar 

  • Christensen, R.D., Brown, M.S., Hall, D.C., Lassiter, H.A., and Hill, H.R. (1991). Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. J Pediatr. 118:606–614.

    Article  PubMed  CAS  Google Scholar 

  • Drossou-Agakidou, V., Kanakoudi-Tsakalidou, F., Sarafidis, K., Taparkou, A., Tzimouli, V., Tsandali, H., and Kremenopoulos, G. (1998). Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial. Eur J Pediatr. 157:583–588.

    Article  PubMed  CAS  Google Scholar 

  • Erdem, G., Yurdakok, M., Tekinalp, G., and Ersoy, F. (1993). The use of IgM-enriched intravenous immunoglobulin for the treatment of neonatal sepsis in preterm infants. Turk J Pediatr. 35:277–281.

    PubMed  CAS  Google Scholar 

  • Fischer, G.W., Cieslak, T.J., Wilson, S.R., Weisman, L.E., and Hemming, V.G. (1994). Opsonic antibodies to Staphylococcus epidermidis: in vitro and in vivo studies using human intravenous immune globulin. J Infect Dis. 169:324–329.

    PubMed  CAS  Google Scholar 

  • Fujiwara, T., Kobayashi, T., Takaya, J., Taniuchi, S., and Kobayashi, Y. (1997). Plasma effects on phagocytic activity and hydrogen peroxide production by polymorphonuclear leukocytes in neonates. Clin Immunol Immunopathol. 85:67–72.

    Article  PubMed  CAS  Google Scholar 

  • Gillan, E.R., Christensen, R.D., Suen, Y., Ellis, R., van de Ven, C., and Cairo, M.S. (1994). A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood. 84:1427–1433.

    PubMed  CAS  Google Scholar 

  • Golan, Y., Doron, S., Sullivan, B., and Snydman, D.R. (2005). Transmission of vancomycin-resistant enterococcus in a neonatal intensive care unit. Pediatr Infect Dis J. 24:566–567.

    Article  PubMed  Google Scholar 

  • Gorgen, I., Hartung, T., Leist, M., Niehorster, M., Tiegs, G., Uhlig, S., Weitzel, F., and Wendel, A. (1992). Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol. 149:918–924.

    PubMed  CAS  Google Scholar 

  • Hanrahan, K.S., and Lofgren, M. (2004) Evidence-based practice: examining the risk of toys in the microenvironment of infants in the neonatal intensive care unit. Adv Neonatal Care. 4:184–201.

    Article  PubMed  Google Scholar 

  • Haque, K.N., Zaidi, M.H., and Bahakim, H. (1988). IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child. 142:1293–1296.

    PubMed  CAS  Google Scholar 

  • Haque, K.N., Khan, M.A., Kerry, S., Stephenson, J., and Woods, G. (2004). Pattern of culture-proven neonatal sepsis in a district general hospital in the United Kingdom. Infect Control Hosp Epidemiol. 25:759–764.

    Article  PubMed  Google Scholar 

  • Heath, P.T., Balfour, G., Weisner, A.M., Efstratiou, A., Lamagni, T.L., Tighe, H., O’Connell, L.A., Cafferkey, M., Verlander, N.Q., Nicoll, A., and McCartney, A.C.; PHLS Group B Streptococcus Working Group. (2004). Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 363:292–294.

    Article  PubMed  Google Scholar 

  • Hunt, D.W., Huppertz, H.I., Jiang, H.J., and Petty, R.E. (1994). Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood. 84:4333–4343.

    PubMed  CAS  Google Scholar 

  • Linkin, D.R., Fishman, N.O., Patel, J.B., Merrill, J.D., and Lautenbach, E. (2004). Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 25:781–783.

    Article  PubMed  Google Scholar 

  • Mancilla-Ramirez, J., Gonzalez-Yunes, R., Castellanos-Cruz, C., Garcia-Roca, P., and Santos-Preciado, J.I. (1992). [Intravenous immunoglobulin in the treatment of neonatal septicemia] Bol Med Hosp Infant Mex. 49:4–11.

    PubMed  CAS  Google Scholar 

  • Manroe, B.L., Weinberg, A.G., Rosenfeld, C.R., and Browne, R. (1979). The neonatal blood count in health and disease.I. Reference values for neutrophilic cells. J Pediatr. 95:89–98.

    Article  PubMed  CAS  Google Scholar 

  • Miura, E., Procianoy, R.S., Bittar, C., Miura, C.S., Miura, M.S., Mello, C., and Christensen, R.D. (2001). A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics. 107:30–35.

    Article  PubMed  CAS  Google Scholar 

  • Mohan, P., and Brocklehurst, P. (2003). Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia. Cochrane Database Syst Rev. 4:CD003956.

    Google Scholar 

  • Mortari, F., Wang, J.Y., and Schroeder, H.W. Jr. (1993). Human cord blood antibody repertoire. Mixed population of VH gene segments and CDR3 distribution in the expressed C alpha and C gamma repertoires. J Immunol. 150:1348–1357.

    PubMed  CAS  Google Scholar 

  • Nonoyama, S., Penix, L.A., Edwards, C.P., Lewis, D.B., Ito, S., Aruffo, A., Wilson, C.B., and Ochs, H.D. (1995). Diminished expression of CD40 ligand by activated neonatal T cells. J Clin Invest. 95:66–75.

    Article  PubMed  CAS  Google Scholar 

  • Ohls, R.K., Li, Y., Abdel-Mageed, A., Buchanan, G., Jr., Mandell, L., and Christensen, R.D. (1995). Neutrophil pool sizes and granulocyte colony-stimulating factor production in human midtrimester fetuses. Pediatr Res. 37:806–811.

    PubMed  CAS  Google Scholar 

  • Ohlsson, A., and Lacy, J.B. (2004a). Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev. 1:CD001239.

    Google Scholar 

  • Ohlsson, A., and Lacy, J.B. (2004b). Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev. 1:CD000361.

    Google Scholar 

  • Punnonen, J., Aversa, G.G., Vandekerckhove, B., Roncarolo, M.G., and de Vries, J.E. (1992). Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells. J Immunol. 148:3398–1404.

    PubMed  CAS  Google Scholar 

  • Regev-Yochay, G., Rubinstein, E., Barzilai, A., Carmeli, Y., Kuint, J., Etienne, J., Blech, M., Smollen, G., Maayan-Metzger, A., Leavitt, A., Rahav, G., and Keller, N. (2005). Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit. Emerg Infect Dis. 11:453–456.

    PubMed  Google Scholar 

  • Ronnestad, A., Abrahamsen, T.G., Medbo, S., Reigstad, H., Lossius, K., Kaaresen, P.I., Engelund, I.E., Irgens, L.M., and Markestad, T. (2005). Septicemia in the first week of life in a Norwegian national cohort of extremely premature infants. Pediatrics. 115: e262–e268.

    Article  PubMed  Google Scholar 

  • Samatha, S., Jalalu, M.P., Hegde, R.K., Vishwanath, D., and Maiya, P.P. (1997). Role of IgM-enriched intravenous immunoglobulin as an adjuvant to antibiotics in neonatal sepsis. Karnataka Pediatr J. 11:1–6.

    Google Scholar 

  • Sanz, I. (1991). Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol. 147:1720–1729.

    PubMed  CAS  Google Scholar 

  • Schelonka, R.L., Chai, M.K., Yoder, B.A., Hensley, D., Brockett, R.M., and Ascher, D.P. (1996). Volume of blood required to detect common neonatal pathogens. J Pediatr. 129:275–278.

    Article  PubMed  CAS  Google Scholar 

  • Schibler, K.R., Osborne, K.A., Leung, L.Y., Le, T.V., Baker, S.I., and Thompson, D.D. (1998). A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics. 102:6–13.

    Article  PubMed  CAS  Google Scholar 

  • Shenoi, A., Nagesh, N.K., Maiya, P.P., Bhat, S.R., and Subba Rao, S.D. (1999). Multicenter randomized placebo controlled trial of therapy with intravenous immunoglobulin in decreasing mortality due to neonatal sepsis. Indian Pediatr. 36:1113–1118.

    PubMed  CAS  Google Scholar 

  • Sidiropoulos, D., Boehme, U., Von Muralt, G., Morell, A., and Barandun, S. (1986). Immunoglobulin supplementation in prevention or treatment of neonatal sepsis. Pediatr Infect Dis. 5:S193–194.

    Article  PubMed  CAS  Google Scholar 

  • Smith, J.B., Campbell, D.E., Ludomirsky, A., Polin, R.A., Douglas, S.D., Garty, B.Z., and Harris, M.C. (1990). Expression of the complement receptors CR1 and CR3 and the type III Fc gamma receptor on neutrophils from newborn infants and from fetuses with Rh disease. Pediatr Res. 28:120–126.

    Article  PubMed  CAS  Google Scholar 

  • Stoll, B.J., Gordon, T., Korones, S.B., Shankaran, S., Tyson, J.E., Bauer, C.R., Fanaroff, A.A., Lemons, J.A., Donovan, E.F., Oh. W., Stevenson, D.K., Ehrenkranz, R.A., Papile, L.A., Verter, J., and Wright, L.L. (1996). Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 129:63–71.

    Article  PubMed  CAS  Google Scholar 

  • Stoll, B.J., Hansen, N., Fanaroff, A.A., Wright, L.L., Carlo, W.A., Ehrenkranz, R.A., Lemons, J.A., Donovan, E.F., Stark, A.R., Tyson, J.E., Oh, W., Bauer, C.R., Korones, S.B., Shankaran, S., Laptook, A.R., Stevenson, D.K., Papile, L.A., and Poole, W.K. (2002). Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 110:285–291.

    Article  PubMed  Google Scholar 

  • Stoll, B.J., Hansen, N.I., Adams-Chapman, I., Fanaroff, A.A., Hintz, S.R., Vohr, B., and Higgins, R.D.; National Institute of Child Health and Human Development Neonatal Research Network. (2004). Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 292:2357–2565.

    Article  PubMed  CAS  Google Scholar 

  • Urrea, M., Iriondo, M., Thio, M., Krauel, X., Serra, M., LaTorre, C., and Jimenez, R. (2003). A prospective incidence study of nosocomial infections in a neonatal care unit. Am J Infect Control. 8:505–507.

    Article  Google Scholar 

  • Weisman, L.E., Stoll, B.J., Kueser, T.J., Rubio, T.T., Frank, C.G., Heiman, H.S., Subramanian, K.N., Hankins, C.T., Anthony, B.F., and Cruess, D.F. (1992). Intravenous immune globulin therapy for early-onset sepsis in premature neonates. J Pediatr. 121:434–443.

    Article  PubMed  CAS  Google Scholar 

  • Weisman, L.E., Cruess, D.F., and Fischer, G.W. (1994). Opsonic activity of commercially available standard intravenous immunoglobulin preparations. Pediatr Infect Dis J. 13:1122–1125.

    Article  PubMed  CAS  Google Scholar 

  • Wheeler, J.G., Chauvenet, A.R., Johnson, C.A., Block, S.M., Dillard, R., and Abramson, J.S. (1987). Buffy coat transfusions in neonates with sepsis and neutrophil storage pool depletion. Pediatrics. 79:422–425.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this paper

Cite this paper

Moss, S.J., Gennery, A.R. (2006). Controversies in Neonatal Sepsis: Immunomodulation in the Treatment and Prevention of Neonatal Sepsis. In: Pollard, A.J., Finn, A. (eds) Hot Topics in Infection and Immunity in Children III. Advances in Experimental Medicine and Biology, vol 582. Springer, Boston, MA . https://doi.org/10.1007/0-387-33026-7_7

Download citation

Publish with us

Policies and ethics